Home
>
National Drug Code (NDC)
>
AcetaZOLAMIDE
AcetaZOLAMIDE - 0615-1511-39 - (AcetaZOLAMIDE)
Drug Information of AcetaZOLAMIDE
| Product NDC: | 0615-1511 |
| Proprietary Name: | AcetaZOLAMIDE |
| Non Proprietary Name: | AcetaZOLAMIDE |
| Active Ingredient(s): | 250 mg/1 & nbsp; AcetaZOLAMIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AcetaZOLAMIDE
| Product NDC: | 0615-1511 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040195 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970528 |
Package Information of AcetaZOLAMIDE
| Package NDC: | 0615-1511-39 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (0615-1511-39) |
NDC Information of AcetaZOLAMIDE
| NDC Code | 0615-1511-39 |
| Proprietary Name | AcetaZOLAMIDE |
| Package Description | 30 TABLET in 1 BLISTER PACK (0615-1511-39) |
| Product NDC | 0615-1511 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | AcetaZOLAMIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970528 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | ACETAZOLAMIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |
